{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T09:44:32Z","timestamp":1750239872881},"reference-count":20,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2018.6937","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T11:33:32Z","timestamp":1541590412000},"source":"Crossref","is-referenced-by-count":7,"title":["Changes in sICAM-1 and GM-CSF levels in skin tissue fluid and expression of IL-6, IL-17 and TNF-\u03b1 in blood of patients with vitiligo"],"prefix":"10.3892","author":[{"given":"Xuesong","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Dermatology, Daqing Long Nan Hospital, Daqing, Heilongjiang 163453, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyi","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Daqing Long Nan Hospital, Daqing, Heilongjiang 163453, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Ha","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Daqing Long Nan Hospital, Daqing, Heilongjiang 163453, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Daqing Long Nan Hospital, Daqing, Heilongjiang 163453, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Daqing Long Nan Hospital, Daqing, Heilongjiang 163453, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Daqing Long Nan Hospital, Daqing, Heilongjiang 163453, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,11,7]]},"reference":[{"key":"key20200713115636_b1-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fendo.2017.00290","article-title":"Vitiligo and autoimmune thyroid disorders","volume":"8","author":"Baldini","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20200713115636_b2-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/bjd.16072","article-title":"Vitiligo and quality of life: The dark face of whiteness","volume":"178","author":"Ezzedine","year":"2018","journal-title":"Br J Dermatol"},{"key":"key20200713115636_b3-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1089\/jir.2012.0171","article-title":"Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo","volume":"33","author":"Dwivedi","year":"2013","journal-title":"J Interferon Cytokine Res"},{"key":"key20200713115636_b4-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/jdv.13256","article-title":"GM-CSF: a possible prognostic serum biomarker of vitiligo patients' considered for transplantation treatment with cultured autologous melanocytes: A pilot study","volume":"30","author":"Wu","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20200713115636_b5-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1080\/10715762.2017.1402303","article-title":"Levels of oxidative damage and proinflammatory cytokines are enhanced in patients with active vitiligo","volume":"51","author":"Mitra","year":"2017","journal-title":"Free Radic Res"},{"key":"key20200713115636_b6-etm-0-0-6937","first-page":"43","article-title":"Assessment of serum levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) among non-segmental vitiligo patients: A pilot study","volume":"24","author":"Abdellatif","year":"2015","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"key20200713115636_b7-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"e81736","DOI":"10.1371\/journal.pone.0081736","article-title":"Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility","volume":"8","author":"Laddha","year":"2013","journal-title":"PLoS One"},{"key":"key20200713115636_b8-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/bjd.14057","article-title":"Tumour necrosis factor-\u03b1 antagonists as therapies for vitiligo","volume":"173","author":"Kemp","year":"2015","journal-title":"Br J Dermatol"},{"key":"key20200713115636_b9-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/bjd.14016","article-title":"Tumour necrosis factor-\u03b1 inhibition can stabilize disease in progressive vitiligo","volume":"173","author":"Webb","year":"2015","journal-title":"Br J Dermatol"},{"key":"key20200713115636_b10-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/ced.12446","article-title":"The combination of tumour necrosis factor-\u03b1 \u2212308A and interleukin-10 \u22121082G gene polymorphisms and increased serum levels of related cytokines: Susceptibility to vitiligo","volume":"40","author":"Ayd\u0131ng\u00f6z","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"key20200713115636_b11-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40257-013-0039-3","article-title":"The role of tumor necrosis factor-\u03b1 in the pathogenesis of vitiligo","volume":"14","author":"Camara-Lemarroy","year":"2013","journal-title":"Am J Clin Dermatol"},{"key":"key20200713115636_b12-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/09674845.2014.11669980","article-title":"Interleukin-6: A possible inflammatory link between vitiligo and type 1 diabetes","volume":"71","author":"Farhan","year":"2014","journal-title":"Br J Biomed Sci"},{"key":"key20200713115636_b13-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.12688\/f1000research.8976.1","article-title":"Recent advances in understanding vitiligo","volume":"5","author":"Manga","year":"2016","journal-title":"F1000Res"},{"key":"key20200713115636_b14-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cyto.2016.12.014","article-title":"Increased systemic and epidermal levels of IL-17A and IL-1\u03b2 promotes progression of non-segmental vitiligo","volume":"91","author":"Bhardwaj","year":"2017","journal-title":"Cytokine"},{"key":"key20200713115636_b15-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/pcmr.12355","article-title":"Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development","volume":"28","author":"Zhou","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20200713115636_b16-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/bjd.14703","article-title":"The many faces of interleukin-17 in inflammatory skin diseases","volume":"175","author":"Speeckaert","year":"2016","journal-title":"Br J Dermatol"},{"key":"key20200713115636_b17-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/ced.12164","article-title":"Stimulated human melanocytes express and release interleukin-8, which is inhibited by luteolin: Relevance to early vitiligo","volume":"39","author":"Miniati","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"key20200713115636_b18-etm-0-0-6937","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1684\/ejd.2013.2023","article-title":"Interleukin 17, interleukin 22 and FoxP3 expression in tissue and serum of non-segmental vitiligo: A case- controlled study on eighty-four patients","volume":"23","author":"Elela","year":"2013","journal-title":"Eur J Dermatol"},{"key":"key20200713115636_b19-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"e000239","DOI":"10.1136\/rmdopen-2015-000239","article-title":"Paradoxical reactions under TNF-\u03b1 blocking agents and other biological agents given for chronic immune-mediated diseases: An analytical and comprehensive overview","volume":"2","author":"Toussirot","year":"2016","journal-title":"RMD Open"},{"key":"key20200713115636_b20-etm-0-0-6937","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s00105-017-4065-6","article-title":"Systemic treatment of vitiligo: Balance and current developments","volume":"68","author":"Meurer","year":"2017","journal-title":"Hautarzt"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T11:00:02Z","timestamp":1594638002000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2018.6937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,7]]},"references-count":20,"URL":"https:\/\/doi.org\/10.3892\/etm.2018.6937","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,7]]}}}